Page last updated: 2024-08-16

ribavirin and Coxsackie Virus Infections

ribavirin has been researched along with Coxsackie Virus Infections in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Carr, MJ; Li, J; Liu, X; Shi, W; Xing, W; Zhang, X; Zhang, Z; Zhou, H1
Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB1
Carr, MJ; Ding, S; Dong, Z; Li, D; Li, J; Shi, W; Tong, Y; Wang, J; Zhang, Y; Zhang, Z; Zhuang, D1
Gao, B; He, X; Xiong, S; Zhou, L1
Jiang, Y; Luo, H; Luo, L; Mu, Q; Shen, X; Zhu, R; Zhu, Y; Zou, X1
Chen, J; Hui, R; Liu, Z; Shi, Y; Song, X; Wang, H; Wang, X; Xin, Y; Zhang, C1
Figulla, HR; Grumbach, I; Heim, A; Kandolf, R; Müller, G; Pring-Akerblom, P; Stille-Siegener, M1
Abelmann, WH; Crumpacker, CS; Kishimoto, C1

Other Studies

8 other study(ies) available for ribavirin and Coxsackie Virus Infections

ArticleYear
Effects of Acetylshikonin on the Infection and Replication of Coxsackievirus A16 in Vitro and in Vivo.
    Journal of natural products, 2019, 05-24, Volume: 82, Issue:5

    Topics: Animals; Animals, Newborn; Anthraquinones; Antineoplastic Agents; Coxsackievirus Infections; Enterovirus; Humans; Interleukin-6; Mice; Mice, Inbred ICR; Virion; Virus Internalization; Virus Replication

2019
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
    Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:11

    Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides

2020
Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Journal of virology, 2017, 07-01, Volume: 91, Issue:13

    Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Coxsackievirus Infections; Disease Models, Animal; Enterovirus; Immunity, Maternally-Acquired; Immunization, Passive; Injections, Intramuscular; Interferon-gamma; Mice, Inbred ICR; Ribavirin; Treatment Outcome; Vaccines, Inactivated; Viral Vaccines; Virus Replication

2017
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Journal of virology, 2015, Volume: 89, Issue:20

    Topics: Androstadienes; Animals; Antiviral Agents; Apoptosis; Autophagy-Related Protein 5; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Myocarditis; Myocardium; Phagosomes; Ribavirin; RNA, Small Interfering; Virus Replication; Vorinostat; Wortmannin

2015
Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Intervirology, 2015, Volume: 58, Issue:6

    Topics: Animals; Antiviral Agents; beta-Defensins; Cell Survival; Coxsackievirus Infections; Enterovirus B, Human; Female; HeLa Cells; Humans; Inflammation; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Recombinant Proteins; Ribavirin; Virus Replication

2015
QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Experimental biology and medicine (Maywood, N.J.), 2007, Volume: 232, Issue:11

    Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coxsackievirus Infections; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Enterovirus B, Human; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Myocarditis; Necrosis; Ribavirin; Vero Cells; Virus Attachment; Virus Internalization

2007
Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha.
    Antiviral research, 1997, Volume: 34, Issue:3

    Topics: Antiviral Agents; Carrier State; Cell Line; Coxsackievirus Infections; Drug Synergism; Enterovirus B, Human; Fibroblasts; Humans; Interferon-alpha; Myocarditis; Myocardium; Ribavirin

1997
Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets.
    Journal of the American College of Cardiology, 1988, Volume: 12, Issue:5

    Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Fluorescent Antibody Technique; Lymphocytes; Male; Mice; Myocarditis; Ribavirin; Ribonucleosides; Spleen; Viral Plaque Assay

1988